Log In
Print this Print this

Tranilast (ALT 401)

  Manage Alerts
Collapse Summary General Information
Company Esperante B.V.
DescriptionAnti-fibrotic which reduces extracellular matrix (ECM)-derived collagen deposition
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsPrevent scarring post glaucoma filtration surgery
Regulatory Designation EU - Orphan Drug (Prevent scarring post glaucoma filtration surgery)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today